EX VIVO ACTIVATED T-LYMPHOCYTIC COMPOSITIONS AND METHODS OF USING THE SAME Application EP-3908293-A4 European Patent Office 11 Jan 2023
IMPROVED TARGETED T-CELL THERAPY FOR TREATMENT OF MULTIPLE MYELOMA Application EP-3908292-A4 European Patent Office 04 Jan 2023
XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE PEPTIDES, AND… Application EP-3919069-A1 European Patent Office 08 Dec 2021